Tech Company Financing Transactions
Laguna Pharmaceuticals Funding Round
Laguna Pharmaceuticals, based in La Jolla, secured investment capital from Sante Ventures.
Transaction Overview
Company Name
Announced On
11/21/2011
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Sante Ventures (Kevin Lalande)
Proceeds Purpose
The company, a spin out of Cleveland-based ChanTest, will use the funding to further evaluate the safety and efficacy of its proprietary AFIB drug, vanoxerine.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
La Jolla, CA 92130
USA
La Jolla, CA 92130
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Laguna Pharmaceuticals, formerly known as ChanRx, is a biopharmaceutical company advancing vanoxerine for treatment of atrial fibrillation and atrial flutter.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bob Baltera
Browse more venture capital transactions:
Prev: 11/21/2011: Amalfi Semiconductor venture capital transaction
Next: 11/21/2011: FitnessKeeper venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs